MoneyWorks4Me

Unichem Laboratories sells balance stake in Optimus Drugs

05 Dec 2023 Evaluate

Unichem Laboratories has sold balance 4918 equity shares representing 0.02% holding in Optimus Drugs to Sekhmet Pharmaventures for an aggregate consideration of Rs 67.47 crore. In May 2022, the company sold 19.97% of equity shares of Optimus to Sekhmet Pharmaventures on a fully diluted basis in the first tranche, for an aggregate consideration of Rs 270.99 crore.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Laboratories Share Price

537.50 6.65 (1.25%)
27-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.50
Dr. Reddys Labs. 1175.00
Cipla 1419.90
Lupin 2164.60
Zydus Lifesciences 1189.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: